Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Biological Psychiatry|October 19, 2010
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography studyFlorence Le Jeune, Marc Vérin, Karim N'Diaye, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 22, 2014
Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudateBruno Millet, Nematollah Jaafari, Mircea Polosan, et al.
Nature Genetics|July 12, 2011
Increased exonic de novo mutation rate in individuals with schizophreniaSimon L Girard, Julie Gauthier, Anne Noreau, et al.
Biological Psychiatry|July 22, 2010
De novo truncating mutation in Kinesin 17 associated with schizophreniaJulien Tarabeux, Nathalie Champagne, Edna Brustein, et al.
Brain : a Journal of Neurology|February 1, 2013
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorderPierre Burbaud, Anne-Hélène Clair, Nicolas Langbour, et al.
Presse Medicale (Paris, France : 1983)|June 4, 2019
[Mood disorders: When should we use repetitive transcranial magnetic stimulation?]Samuel Bulteau, Charline Guirette, Jérôme Brunelin, et al.
Brain Communications|August 17, 2021
The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centreCécile Delorme, Marion Houot, Charlotte Rosso, et al.
The New England Journal of Medicine|November 14, 2008
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderLuc Mallet, Mircea Polosan, Nematollah Jaafari, et al.
American Journal of Human Genetics|August 28, 2010
Direct measure of the de novo mutation rate in autism and schizophrenia cohortsPhilip Awadalla, Julie Gauthier, Rachel A Myers, et al.
Molecular Psychiatry|February 19, 2026
Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium studyAda Man-Choi Ho, Brandon J Coombes, Anthony Batzler, et al.
Pageof 8